Press "Enter" to skip to content

New patent for Abbvie Inc drug MAVYRET

0

Annual Drug Patent Expirations for MAVYRET
Annual Drug Patent Expirations for MAVYRET

Mavyret is a drug marketed by Abbvie Inc
and is included in one NDA. It is available from one supplier.

The generic ingredient in MAVYRET is glecaprevir; pibrentasvir. One supplier is listed for this compound. Additional details are available on the glecaprevir; pibrentasvir profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs,
contact admin@DrugPatentWatch.com
or visit www.DrugPatentWatch.com

    Do NOT follow this link or you will be banned from the site!